TickerFacts.

Compare

UL Solutions Inc. vs NeoGenomics Inc vs Hypha Labs, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearUL Solutions Inc.
ULS		NeoGenomics Inc
NEO		Hypha Labs, Inc.
FUNI
Year ended2025-12-312025-12-312025-09-30
Revenue$3.05B$727.33Mn/a
Revenue growth (YoY)+6.4%+10.1%n/a
Gross margin49.5% (computed)43.2%n/a
Operating margin17.1%-15.9%n/a
Net margin10.6%-14.9%n/a
Net income$325.00M-$108.03M-$3.10M
EPS (Diluted)$1.60n/a-$0.02
Operating cash flow$600.00M$5.23M-$380.0K
Free cash flow$403.00M-$21.78M-$412.9K
Cash & equivalents$295.00M$159.62Mn/a
Total assets$2.92B$1.36B$409.2K
Total liabilities$1.63B$523.27M$2.51M
Shareholders' equity$1.29B$836.56M-$2.44M
Return on year-end equity25.1%-12.9%n/a
Shares outstanding201.03M128.15M147.12M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearUL Solutions Inc.NeoGenomics IncHypha Labs, Inc.
Latest$3.05B
Ended 2025-12-31		$727.33M
Ended 2025-12-31		$2.70M
Ended 2022-09-30
1 year earlier$2.87B
Ended 2024-12-31		$660.57M
Ended 2024-12-31		$2.50M
Ended 2021-09-30
2 years earlier$2.68B
Ended 2023-12-31		$591.64M
Ended 2023-12-31		$2.57M
Ended 2020-09-30
3 years earlier$2.52B
Ended 2022-12-31		$509.73M
Ended 2022-12-31		$2.55M
Ended 2019-09-30
4 years earliern/a$484.33M
Ended 2021-12-31		$2.84M
Ended 2018-09-30